Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation
暂无分享,去创建一个
L. Elo | C. Bock | W. Ellmeier | A. Visekruna | T. Decker | A. Laiho | C. Seiser | B. Bohle | B. Strobl | G. Steiner | S. Sakaguchi | Roland Tschismarov | Valentina Stolz | Nicole Boucheron | L. Göschl | Maik Luu | Patricia Hamminger | T. Preglej | Thomas Faux | Thorina Boenke | Tanja Bulat | D. Waltenberger | Liisa Andersen | Lisa Sandner | R. Rica | Darina Waltenberger
[1] B. Vervliet,et al. The role of short-chain fatty acids in microbiota–gut–brain communication , 2019, Nature Reviews Gastroenterology & Hepatology.
[2] Ruxolitinib , 2019, Reactions Weekly.
[3] J. Karrich,et al. IL-10 signaling prevents gluten-dependent intraepithelial CD4+ cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine , 2018, Mucosal Immunology.
[4] W. Ellmeier,et al. Histone deacetylase function in CD4+ T cells , 2018, Nature Reviews Immunology.
[5] S. Forman,et al. Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity. , 2018, JCI insight.
[6] Jishnu Das,et al. The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes , 2018, eLife.
[7] Bjoern Peters,et al. Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis , 2018, Science Immunology.
[8] Ying Hu,et al. TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance , 2017, Science Translational Medicine.
[9] J. O’Shea,et al. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases , 2017, Nature Reviews Drug Discovery.
[10] A. Rosato,et al. Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells , 2017, Front. Immunol..
[11] Takashi Saito,et al. CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function , 2017, Front. Immunol..
[12] S. Kent,et al. Cytotoxic CD4 T Cells—Friend or Foe during Viral Infection? , 2017, Front. Immunol..
[13] S. Nutt,et al. Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus , 2016, Cell reports.
[14] H. M. Silva,et al. Tissue adaptation of regulatory and intraepithelial CD4+ T cells controls gut inflammation , 2016, Science.
[15] M. Kubo,et al. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage , 2016, The Journal of experimental medicine.
[16] J. Mesirov,et al. The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .
[17] Bjoern Peters,et al. Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection , 2015, Journal of Virology.
[18] W. Ellmeier. Molecular control of CD4(+) T cell lineage plasticity and integrity. , 2015, International immunopharmacology.
[19] S. Grivennikov,et al. Transcription factor T-bet regulates intraepithelial lymphocyte functional maturation. , 2014, Immunity.
[20] R. Johnstone,et al. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders , 2014, Nature Reviews Drug Discovery.
[21] Y. Belkaid,et al. A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4+ T cells , 2014, Nature Immunology.
[22] Chunaram Choudhary,et al. The growing landscape of lysine acetylation links metabolism and cell signalling , 2014, Nature Reviews Molecular Cell Biology.
[23] K. Bennett,et al. CD4+ T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2 , 2014, Nature Immunology.
[24] H. Lassmann,et al. A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog , 2014, Development.
[25] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[26] P. Matthias,et al. Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis , 2013, The EMBO journal.
[27] H. Cheroutre,et al. CD4 CTL: living up to the challenge. , 2013, Seminars in immunology.
[28] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[29] L. Wessels,et al. Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function. , 2013, Blood.
[30] K. Honda,et al. Transcriptional Reprogramming of Mature CD4+ T helper Cells generates distinct MHC class II-restricted Cytotoxic T Lymphocytes , 2013, Nature Immunology.
[31] Aneta Rogoz,et al. Mutual expression of Runx3 and ThPOK regulates intestinal CD4+ T cell immunity , 2012, Nature Immunology.
[32] V. Sexl,et al. Conditional Stat1 Ablation Reveals the Importance of Interferon Signaling for Immunity to Listeria monocytogenes Infection , 2012, PLoS pathogens.
[33] David R. Kelley,et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.
[34] T. Rülicke,et al. Generation of mice with a conditional Stat1 null allele , 2012, Transgenic Research.
[35] John J. O’Shea,et al. Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550) , 2011, The Journal of Immunology.
[36] W. Ellmeier,et al. Conditional Deletion of Histone Deacetylase 1 in T Cells Leads to Enhanced Airway Inflammation and Increased Th2 Cytokine Production , 2010, The Journal of Immunology.
[37] Min Zhang,et al. p300-Mediated Acetylation Stabilizes the Th-Inducing POK Factor , 2010, The Journal of Immunology.
[38] P. Muranski,et al. Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma , 2010, The Journal of experimental medicine.
[39] R. Blasberg,et al. Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts , 2010, The Journal of experimental medicine.
[40] D. Schrenk,et al. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. , 2008, The Journal of nutritional biochemistry.
[41] A. Oxenius,et al. The Dynamics of Mouse Cytomegalovirus-Specific CD4 T Cell Responses during Acute and Latent Infection1 , 2008, The Journal of Immunology.
[42] Bjoern Peters,et al. Cutting Edge: Murine Cytomegalovirus Induces a Polyfunctional CD4 T Cell Response1 , 2008, The Journal of Immunology.
[43] M. Grusby,et al. IL-21 Inhibits IFN-γ Production in Developing Th1 Cells through the Repression of Eomesodermin Expression1 , 2006, The Journal of Immunology.
[44] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] E. Remmerswaal,et al. Emergence of a CD4+CD28− Granzyme B+, Cytomegalovirus-Specific T Cell Subset after Recovery of Primary Cytomegalovirus Infection , 2004, The Journal of Immunology.
[46] L. Augenlicht,et al. Requirement of Histone Deacetylase Activity for Signaling by STAT1* , 2004, Journal of Biological Chemistry.
[47] S. Jonjić,et al. Gain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus , 2004, Journal of Virology.
[48] Wun-Jae Kim,et al. Transforming Growth Factor-β Stimulates p300-dependent RUNX3 Acetylation, Which Inhibits Ubiquitination-mediated Degradation* , 2004, Journal of Biological Chemistry.
[49] C. Horvath,et al. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] R. Koup,et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.
[51] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[52] Anthony D. Kelleher,et al. Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.
[53] H. Macdonald,et al. Inactivation of Notch1 in immature thymocytes does not perturb CD4 or CD8 T cell development , 2001, Nature Immunology.
[54] S. Fujita,et al. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. , 2000, Blood.
[55] J. Girdlestone,et al. Autocrine activation by interferon‐γ of STAT factors following T cell activation , 1996 .
[56] C. Bock,et al. A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis. , 2018, Journal of Autoimmunity.
[57] C. Mackay,et al. The role of short-chain fatty acids in health and disease. , 2014, Advances in immunology.
[58] Deborah M. Brown,et al. IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells. , 2009, Cellular immunology.
[59] E. Olson,et al. The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.
[60] H. Macdonald,et al. Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. , 2001, Nature immunology.
[61] J. Girdlestone,et al. Autocrine activation by interferon-gamma of STAT factors following T cell activation. , 1996, European journal of immunology.